Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...

Uniqure N.V. (NASDAQ: QURE) has announced the pricing of its public offering of 4,411,764 ordinary shares at a price of ...

Stock analysts at Leerink Partnrs decreased their Q4 2025 earnings per share (EPS) estimates for Illumina in a note issued to ...

Leerink Partnrs analyst M. Cherny now forecasts that the medical research company will post earnings of $14.53 per share for ...

Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...

In recent trading, Tenaya Therapeutics Inc (TNYA) stock price has shown some volatility, fluctuating -0.70% over the last five trades a ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...